Expect Boston Scientific's Rhythm Management Growth To Slow Down

Boston Scientific's Rhythm Management business accounts for around 20% of the company's value, according to our estimates. The segment primarily includes products such as pacemakers, implantable cardioverter defibrillators (ICDs), and electrophysiology products.